{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:46:12Z","timestamp":1770421572667,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03642-5","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T14:15:15Z","timestamp":1734185715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparing the efficacy of oral apremilast, intralesional corticosteroids, and their combination in patients with patchy alopecia areata: a randomized clinical controlled trial"],"prefix":"10.1007","volume":"317","author":[{"given":"Sankalp","family":"Awasthi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Nijhawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anviti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,14]]},"reference":[{"issue":"1","key":"3642_CR1","first-page":"1","volume":"3","author":"CH Pratt","year":"2017","unstructured":"Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP (2017) Alopecia Areata. Nat Rev Dis Prim 3(1):1\u201317","journal-title":"Nat Rev Dis Prim"},{"issue":"2","key":"3642_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaad.2009.10.032","volume":"62","author":"A Alkhalifah","year":"2010","unstructured":"Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J (2010) Alopecia Areata update: part I. clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 62(2):177\u2013188","journal-title":"J Am Acad Dermatol"},{"key":"3642_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1067\/mjd.2000.103909","volume":"42","author":"S Madani","year":"2000","unstructured":"Madani S, Shapiro J (2000) Alopecia Areata update. J Am Acad Dermatol 42:549\u2013566","journal-title":"J Am Acad Dermatol"},{"key":"3642_CR4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1529-8019.2011.01413.x","volume":"24","author":"AM Finner","year":"2011","unstructured":"Finner AM (2011) Alopecia Areata: clinical presentation, diagnosis, and unusual cases. Dermatol Ther 24:348\u2013354","journal-title":"Dermatol Ther"},{"key":"3642_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4103\/ijt.ijt_99_17","volume":"10","author":"E Darwin","year":"2018","unstructured":"Darwin E, Hirt PA, Fertig R, Doliner B, Delcanto G, Jimenez JJ (2018) Alopecia Areata: review of epidemiology, clinical features, pathogenesis, and new treatment options. Int J Trichology 10:51\u201360","journal-title":"Int J Trichology"},{"key":"3642_CR6","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1007\/s12325-017-0542-7","volume":"34","author":"Y Renert-Yuval","year":"2017","unstructured":"Renert-Yuval Y, Guttman-Yassky E (2017) The changing landscapeof alopecia areata: the therapeutic paradigm. Adv Ther 34:1594\u20131609","journal-title":"Adv Ther"},{"issue":"6","key":"3642_CR7","first-page":"e404","volume":"115","author":"KJ Ju\u00e1rez-Rend\u00f3n","year":"2017","unstructured":"Ju\u00e1rez-Rend\u00f3n KJ et al (2017) Alopecia Areata: Actualidad Y perspectivas. Arch Argent Pediatr 115(6):e404\u2013e411","journal-title":"Arch Argent Pediatr"},{"issue":"10","key":"3642_CR8","first-page":"674","volume":"71","author":"EP Kubeyinje","year":"1994","unstructured":"Kubeyinje EP (1994) Intralesional triamcinolone acetonide in Alopecia Areata amongst 62 Saudi arabs. East Afr Med J 71(10):674\u2013675","journal-title":"East Afr Med J"},{"issue":"4","key":"3642_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/exd.12918","volume":"25","author":"J Fuentes-Duculan","year":"2016","unstructured":"Fuentes-Duculan J et al (2016) Biomarkers of Alopecia Areata disease activity and response to corticosteroid treatment. Exp Dermatol 25(4):282\u2013286","journal-title":"Exp Dermatol"},{"issue":"1","key":"3642_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-4362.1996.tb01610.x","volume":"35","author":"VK Sharma","year":"1996","unstructured":"Sharma VK, Dawn G, Kumar B (1996) Profile of Alopecia Areata in Northern India. Int J Dermatol 35(1):22\u201327","journal-title":"Int J Dermatol"},{"issue":"11","key":"3642_CR11","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1046\/j.1365-4362.2002.01357.x","volume":"41","author":"E Tan","year":"2002","unstructured":"Tan E, Tay Y, Goh C, Chin Giam Y (2002) The pattern and profile of Alopecia Areata in Singapore\u2013a study of 219 asians. Int J Dermatol 41(11):748\u2013753","journal-title":"Int J Dermatol"},{"key":"3642_CR12","doi-asserted-by":"crossref","unstructured":"Guttman-Yassky E, Ungar B et al (2016) Extensive alopecia areata is reversed by IL-12\/IL-23p40 cytokine antagonism. J Allergy Clin Immunol; 137: 301-4.Elise A. Olsen, Alopecia areata investigational assessment guidelines\u2013Part II, Journal of the American Academy of Dermatology, Volume 51, Issue 3","DOI":"10.1016\/j.jaci.2015.11.001"},{"issue":"2","key":"3642_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jaad.2015.04.049","volume":"73","author":"TW Chu","year":"2015","unstructured":"Chu TW, AlJasser M, Alharbi A, Abahussein O, McElwee K, Shapiro J (2015) Benefit of different concentrations of intralesional triamcinolone acetonide in Alopecia Areata: an intrasubject pilot study. J Am Acad Dermatol 73(2):338\u2013340","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"3642_CR14","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.18203\/2349-3933.ijam20173254","volume":"4","author":"S Srivastava","year":"2017","unstructured":"Srivastava S, Goyal S, Dhillon KS, Singh N (2017) Dermoscopic evaluation of therapeutic response to intralesional triamcinolone acetonide in the treatment of Alopecia Areata. Int J Adv Med 4(4):1175","journal-title":"Int J Adv Med"},{"key":"3642_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1165\/rcmb.2008-0091TR","volume":"39","author":"CH Serezani","year":"2008","unstructured":"Serezani CH, Ballinger MN, Aronoff DM, Peters-Golden M (2008) Cyclic AMP: master regulator of innate immune cell function. Am J Respir Cell Mol Biol 39:127\u2013132","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3642_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00021.2003","volume":"84","author":"K Tasken","year":"2004","unstructured":"Tasken K, Aandahl EM (2004) Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev 84:137\u2013167","journal-title":"Physiol Rev"},{"key":"3642_CR17","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.bcp.2012.01.001","volume":"83","author":"P Schafer","year":"2012","unstructured":"Schafer P (2012) Apremilast mechanism of action and application to psoriasis and psoriatic arthritis. Biochem Pharmacol 83:1583\u20131590","journal-title":"Biochem Pharmacol"},{"key":"3642_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/ajd.12934","volume":"60","author":"J Magdaleno-Tapial","year":"2019","unstructured":"Magdaleno-Tapial J, Valenzuela-O\u02dcnate C, S\u00e1nchez-Carazo JL, Alegre-de Miquel V (2019) Improvement of Alopecia Areata with apremilast. Australas J Dermatol 60:144\u2013145","journal-title":"Australas J Dermatol"},{"key":"3642_CR19","first-page":"2","volume":"1","author":"SD Lopez","year":"2017","unstructured":"Lopez SD, Castro C, Calzada P et al (2017) Alopecia Areata and severe psoriasis successfully treated with apremilast. Arch Clin Dermatol 1:2","journal-title":"Arch Clin Dermatol"},{"key":"3642_CR20","first-page":"1","volume":"6","author":"N Taneja","year":"2019","unstructured":"Taneja N, Gupta S (2019) Apremilast is efficacious in refractory alopecia areata. J Dermatolog Treat 6:1\u20133","journal-title":"J Dermatolog Treat"},{"key":"3642_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/ijt.ijt_59_19","volume":"11","author":"A Est\u00e9banez","year":"2019","unstructured":"Est\u00e9banez A, Est\u00e9banez N, Martin JM, Montesinos E (2019) Apremilast in refractory alopecia areata. Int J Trichology 11:213\u2013215","journal-title":"Int J Trichology"},{"key":"3642_CR22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1684\/ejd.2019.3576","volume":"29","author":"M Sakakibara","year":"2019","unstructured":"Sakakibara M, Shimoyama H, Nomura M et al (2019) Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe Alopecia Areata. Eur J Dermatol 29:436\u2013437","journal-title":"Eur J Dermatol"},{"key":"3642_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jaad.2017.05.034","volume":"77","author":"LY Liu","year":"2017","unstructured":"Liu LY, King BA (2017) Lack of efficacy of apremilast in 9 patients with severe Alopecia Areata. J Am Acad Dermatol 77:773\u2013774","journal-title":"J Am Acad Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03642-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03642-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03642-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T15:02:14Z","timestamp":1734188534000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03642-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,14]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3642"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03642-5","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,14]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Taken.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Taken.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent from the patient"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}